Menu

Contact us

EMO-FARM Sp. z o.o.
ul. Łódzka 52
95-054 Ksawerów
phone: +48 42 212 80 85
www.emo-farm.pl; www.emo-farm.com    
e-mail: emo-farm@bauschhealth.com

Tax Identification Number: PL 7311855351
National Official Business Register Number:
473107958
Share capital of
3 306 000 PLN

A company with its registered office in Ksawerów, address: Łódzka 52,
95-054 Ksawerów/Poland, entered in the register of businesses conducted by the District Court in Łódź, XX Division of the National Court Register, as KRS number 0000147075.

 

Search a product

If you are looking for a specific product enter the name or key word.

About us

The “EMO” Pharmaceuticals and Cosmetics Plant” founded in 1983 was a precursor of the EMO-FARM Ltd…

Product Name: MaxiBiotic
Category: antibiotics for topical use
Form: ointment
Active substance: Neomycin sulphate ,Polymyxin B sulphate, Bacitracin zinc
Availability: OTC - without prescription
Package: Tube 5 g, 10 sachets of 1g
MaxiBiotic

THERAPEUTIC INDICATIONS:
The topical treatment of:
- slight injuries (abrasions, scratches, bites),
- skin burns,
- cutaneous ulceration.

 

POSOLOGY AND METHOD OF ADMINISTRATION:
The medicinal product MAXIBIOTIC is for the topical administration on the skin. The injury site should be cleaned and covered with the slight amount of the drug. MAXIBIOTIC should be applied to the sore skin 2 to 5 times a day. The application site could be covered either with bandages or left uncovered. Do not use longer than 7 days.
After the termination of treatment, do not use the drug before 3 months.
Children: MAXIBIOTIC is recommended for children older then 12 years old, because of the risk of ototoxicity and nefrotoxicity

 

CONTRAINDICATIONS:
Do not use the drug:
- in hypersensitivity of active substances - neomycin sulphate, Polymyxin B sulphate, bacitracin zinc or to any of the excipients of the medicinal product,
- in case of hearing disturbances,
- on eyes,
- on deep or stab wounds, severe burns, large areas of injured skin and oozing lesions, because of the risk of absorption of active substances into systemic circulation and causing systemic adverse reactions (ototoxicity and nephrotoxicity)

- in children under 12 years old.

 

QUALITATIVE AND QUANTITATIVE COMPOSITION:
Active substances: neomycin sulphate (Neomycini sulfas) 5mg/g, Polymyxin B sulphate (Polymyxini B sulfas) 5000 j.m./g, Bacitracin zinc (Bacitracinum zincum) 400 j.m/g.
The excipient: white vaseline.